China Universal Asset Management Company’s Pliant Therapeutics PLRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,760
Closed -$15.9K 522
2025
Q3
$15.9K Sell
10,760
-1,569
-13% -$2.39K ﹤0.01% 465
2025
Q2
$14.3K Buy
12,329
+123
+1% +$174 ﹤0.01% 457
2025
Q1
$16.5K Sell
12,206
-697
-5% -$4.23K ﹤0.01% 461
2024
Q4
$170K Buy
12,903
+1,209
+10% +$16.5K 0.02% 338
2024
Q3
$131K Buy
11,694
+4,607
+65% +$57.6K 0.01% 334
2024
Q2
$76.2K Sell
7,087
-4,494
-39% -$57.9K 0.01% 320
2024
Q1
$173K Buy
11,581
+4,652
+67% +$76.7K 0.02% 310
2023
Q4
$125K Buy
6,929
+5,400
+353% +$82.1K 0.02% 253
2023
Q3
$26.5K Buy
1,529
+754
+97% +$13.1K 0.01% 279
2023
Q2
$14K Buy
775
+2
+0.3% +$47 ﹤0.01% 298
2023
Q1
$20.6K Buy
773
+278
+56% +$7.92K 0.01% 217
2022
Q4
$9.57K Buy
495
+39
+9% +$815 ﹤0.01% 231
2022
Q3
$10K Buy
+456
New +$8.72K ﹤0.01% 207

Other funds holding PLRX